Guardant Health Inc. Common Stock vs Kenvue Inc. Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $167.93 (market cap $22.22B), while Kenvue Inc. Common Stock trades at $17.72 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals.
| GH | KVUE | |
|---|---|---|
Market Cap | $22.22B | $34.06B |
Volume | 1,589,453 | 23,267,228 |
Sector | Health | Consumer Staples |
52-Week High | $187.22 | $19.83 |
52-Week Low | $61.73 | $14.11 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $22.86B | $41.56B |
Dividend Yield | — | 4.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →